JP2018500012A5 - - Google Patents

Download PDF

Info

Publication number
JP2018500012A5
JP2018500012A5 JP2017526681A JP2017526681A JP2018500012A5 JP 2018500012 A5 JP2018500012 A5 JP 2018500012A5 JP 2017526681 A JP2017526681 A JP 2017526681A JP 2017526681 A JP2017526681 A JP 2017526681A JP 2018500012 A5 JP2018500012 A5 JP 2018500012A5
Authority
JP
Japan
Prior art keywords
rodent
gene
human
polypeptide
humanized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017526681A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018500012A (ja
JP6730277B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/062614 external-priority patent/WO2016089692A1/en
Publication of JP2018500012A publication Critical patent/JP2018500012A/ja
Publication of JP2018500012A5 publication Critical patent/JP2018500012A5/ja
Application granted granted Critical
Publication of JP6730277B2 publication Critical patent/JP6730277B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017526681A 2014-12-05 2015-11-25 ヒト化されたｃｌｕｓｔｅｒ ｏｆ ｄｉｆｆｅｒｅｎｔｉａｔｉｏｎ ４７遺伝子を有する非ヒト動物 Active JP6730277B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462087992P 2014-12-05 2014-12-05
US62/087,992 2014-12-05
PCT/US2015/062614 WO2016089692A1 (en) 2014-12-05 2015-11-25 Non-human animals having a humanized cluster of differentiation 47 gene

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020114628A Division JP7089554B2 (ja) 2014-12-05 2020-07-02 ヒト化されたｃｌｕｓｔｅｒ ｏｆ ｄｉｆｆｅｒｅｎｔｉａｔｉｏｎ ４７遺伝子を有する非ヒト動物

Publications (3)

Publication Number Publication Date
JP2018500012A JP2018500012A (ja) 2018-01-11
JP2018500012A5 true JP2018500012A5 (cg-RX-API-DMAC7.html) 2018-12-13
JP6730277B2 JP6730277B2 (ja) 2020-07-29

Family

ID=54979926

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017526681A Active JP6730277B2 (ja) 2014-12-05 2015-11-25 ヒト化されたｃｌｕｓｔｅｒ ｏｆ ｄｉｆｆｅｒｅｎｔｉａｔｉｏｎ ４７遺伝子を有する非ヒト動物
JP2020114628A Active JP7089554B2 (ja) 2014-12-05 2020-07-02 ヒト化されたｃｌｕｓｔｅｒ ｏｆ ｄｉｆｆｅｒｅｎｔｉａｔｉｏｎ ４７遺伝子を有する非ヒト動物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020114628A Active JP7089554B2 (ja) 2014-12-05 2020-07-02 ヒト化されたｃｌｕｓｔｅｒ ｏｆ ｄｉｆｆｅｒｅｎｔｉａｔｉｏｎ ４７遺伝子を有する非ヒト動物

Country Status (29)

Country Link
US (5) US20160345549A1 (cg-RX-API-DMAC7.html)
EP (4) EP4296278A3 (cg-RX-API-DMAC7.html)
JP (2) JP6730277B2 (cg-RX-API-DMAC7.html)
KR (3) KR102313073B1 (cg-RX-API-DMAC7.html)
CN (2) CN107205368B (cg-RX-API-DMAC7.html)
AR (1) AR102888A1 (cg-RX-API-DMAC7.html)
AU (2) AU2015355328B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017010490A2 (cg-RX-API-DMAC7.html)
CA (1) CA2967834C (cg-RX-API-DMAC7.html)
CY (2) CY1121547T1 (cg-RX-API-DMAC7.html)
DK (3) DK3086637T3 (cg-RX-API-DMAC7.html)
ES (3) ES2969389T3 (cg-RX-API-DMAC7.html)
FI (1) FI3850946T3 (cg-RX-API-DMAC7.html)
HR (3) HRP20190634T1 (cg-RX-API-DMAC7.html)
HU (3) HUE054661T2 (cg-RX-API-DMAC7.html)
IL (2) IL286403B2 (cg-RX-API-DMAC7.html)
LT (3) LT3086637T (cg-RX-API-DMAC7.html)
MX (1) MX2017007293A (cg-RX-API-DMAC7.html)
NZ (2) NZ731471A (cg-RX-API-DMAC7.html)
PL (3) PL3086637T3 (cg-RX-API-DMAC7.html)
PT (3) PT3850946T (cg-RX-API-DMAC7.html)
RS (3) RS58536B1 (cg-RX-API-DMAC7.html)
RU (1) RU2728412C2 (cg-RX-API-DMAC7.html)
SG (2) SG11201703463WA (cg-RX-API-DMAC7.html)
SI (3) SI3466255T1 (cg-RX-API-DMAC7.html)
SM (3) SMT201900178T1 (cg-RX-API-DMAC7.html)
TR (1) TR201903891T4 (cg-RX-API-DMAC7.html)
TW (1) TWI681053B (cg-RX-API-DMAC7.html)
WO (1) WO2016089692A1 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL286403B2 (en) 2014-12-05 2023-10-01 Regeneron Pharma Non-human animals possess a humanized CLUSTER OF DIFFERENTIATION 47 gene
HUE067123T2 (hu) 2014-12-09 2024-10-28 Regeneron Pharma Humanizált differenciációs klaszter 274 génnel rendelkezõ nem humán állatok
WO2016154299A1 (en) * 2015-03-24 2016-09-29 The Trustees Of Columbia University In The City Of New York Genetic modification of pigs for xenotransplantation
RU2725737C2 (ru) 2015-05-29 2020-07-03 Регенерон Фармасьютикалс, Инк. Животные, отличные от человека, с нарушением в локусе c9orf72
JP6997708B2 (ja) 2015-11-20 2022-02-04 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化されたｌｙｍｐｈｏｃｙｔｅ－ａｃｔｉｖａｔｉｏｎ ｇｅｎｅ ３遺伝子を有する非ヒト動物
SG11201806176PA (en) 2016-02-04 2018-08-30 Regeneron Pharma Non-human animals having an engineered angptl8 gene
AU2017228293B2 (en) 2016-02-29 2023-05-25 Regeneron Pharmaceuticals, Inc. Rodents having a humanized Tmprss gene
JP7134944B2 (ja) * 2016-08-11 2022-09-12 ザ ジャクソン ラボラトリー 遺伝子改変免疫不全非ヒト動物における改良されたヒト赤血球生存に関連する方法および組成物
WO2018041119A1 (en) 2016-08-31 2018-03-08 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric ox40
WO2018041121A1 (en) 2016-08-31 2018-03-08 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric ctla-4
CN107815465B (zh) * 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
CN107815468B (zh) 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
CA3038548A1 (en) * 2016-09-30 2018-04-05 Regeneron Pharmaceuticals, Inc. Non-human animals having a hexanucleotide repeat expansion in a c9orf72 locus
CN108467873B (zh) 2017-03-17 2020-03-13 百奥赛图江苏基因生物技术有限公司 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用
WO2018177441A1 (en) 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
CN108588126B (zh) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Cd47基因人源化改造动物模型的制备方法及应用
CN110869494B (zh) * 2017-06-12 2025-02-18 西奈卫生系统公司 无需全身性免疫遏制的同种异体移植物耐受
NZ761568A (en) 2017-08-02 2022-11-25 Phanes Therapeutics Inc Anti-cd47 antibodies and uses thereof
IL274740B2 (en) * 2017-11-30 2024-06-01 Regeneron Pharma Non-human animals comprising a humanized trkb locus
CA3093850A1 (en) 2018-03-26 2019-10-03 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
FI3823443T3 (fi) 2018-07-16 2024-07-25 Regeneron Pharma Ditra-taudin jyrsijämallit ja niiden käyttö
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
CA3120799A1 (en) 2018-12-20 2020-06-25 Regeneron Pharmaceuticals, Inc. Nuclease-mediated repeat expansion
WO2020147829A1 (zh) * 2019-01-17 2020-07-23 北京百奥赛图基因生物技术有限公司 人源化转基因动物
WO2021027737A1 (en) * 2019-08-09 2021-02-18 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il2ra
US20220346357A1 (en) * 2019-09-06 2022-11-03 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric tnfr2
WO2021136537A1 (en) * 2019-12-31 2021-07-08 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα/CD47
CN112080522A (zh) * 2020-09-15 2020-12-15 广东药康生物科技有限公司 一种cd47人源化小鼠模型的构建方法
CN112725379B (zh) * 2021-01-27 2024-08-13 上海南方模式生物科技股份有限公司 人源化cd40基因改造动物模型的构建方法及应用
CN116064558A (zh) * 2021-09-24 2023-05-05 百奥赛图(北京)医药科技股份有限公司 Trop2基因人源化非人动物的构建方法及应用
US20240102045A1 (en) 2022-07-19 2024-03-28 Regeneron Pharmaceuticals, Inc. Vectors, genetically modified cells, and genetically modified non-human animals comprising the same
WO2025171307A1 (en) 2024-02-08 2025-08-14 Regeneron Pharmaceuticals, Inc. Vectors, genetically modified cells, and genetically modified non-human animals comprising the same

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
EP1693385A4 (en) * 2003-11-11 2009-11-04 Chugai Pharmaceutical Co Ltd ANTI-CD47 ANTIBODIES HUMANIZED
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
US20070113297A1 (en) 2005-09-13 2007-05-17 Yongguang Yang Methods and compositions for inhibition of immune responses
SG174053A1 (en) * 2006-09-01 2011-09-29 Therapeutic Human Polyclonals Inc Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
WO2009039244A2 (en) * 2007-09-18 2009-03-26 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
CN101668387A (zh) 2008-09-02 2010-03-10 鸿富锦精密工业（深圳）有限公司 印刷电路板
JP5073836B2 (ja) * 2009-01-16 2012-11-14 公益財団法人実験動物中央研究所 ヒト肝細胞が移植されたマウス
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
US8354389B2 (en) 2009-08-14 2013-01-15 Regeneron Pharmaceuticals, Inc. miRNA-regulated differentiation-dependent self-deleting cassette
EP4134095A1 (en) * 2009-09-15 2023-02-15 The Board of Trustees of the Leland Stanford Junior University Synergistic anti-cd47 therapy for hematologic cancers
ES2700852T3 (es) 2009-10-06 2019-02-19 Regeneron Pharma Ratones modificados genéticamente e injerto
KR102256316B1 (ko) 2011-02-15 2021-05-28 리제너론 파마슈티칼스 인코포레이티드 인간화된 ｍ－ｃｓｆ 마우스
WO2013056352A1 (en) * 2011-10-19 2013-04-25 University Health Network Antibodies and antibody fragments targeting sirp-alpha and their use in treating hematologic cancers
ES2741649T3 (es) 2011-10-28 2020-02-11 Regeneron Pharma Ratones con complejo mayor de histocompatibilidad modificado genéticamente
CA2853731C (en) 2011-10-28 2021-05-18 Regeneron Pharmaceuticals, Inc. Humanized il-6 and il-6 receptor
CN104039133B (zh) 2011-10-28 2018-05-04 瑞泽恩制药公司 表达嵌合主要组织相容性复合物(mhc)ii类分子的基因修饰小鼠
EP2644027A1 (en) * 2012-03-26 2013-10-02 Institut Pasteur Transgenic immunodefficient mouse expressing human SIRPalpha.
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
CN108782459B (zh) 2012-09-07 2021-11-05 再生元制药公司 经遗传修饰的非人动物及其使用方法
IL299887B2 (en) * 2012-11-05 2024-09-01 Regeneron Pharma Genetically modified non-human animals and methods of use thereof
JP6572131B2 (ja) * 2012-12-12 2019-09-04 バスキュロックス インコーポレイテッド 治療用ｃｄ４７抗体
KR102714111B1 (ko) 2013-02-20 2024-10-11 리제너론 파아마슈티컬스, 인크. 사람화된 ｔ-세포 보조-수용체를 발현하는 마우스
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
HRP20181866T1 (hr) 2013-02-22 2019-01-25 Regeneron Pharmaceuticals, Inc. Miševi koji izražavaju humanizirane komplekse glavne histokompatibilnosti
KR102370419B1 (ko) 2013-09-23 2022-03-04 리제너론 파마슈티칼스 인코포레이티드 인간화된 신호-조절 단백질 유전자를 가지는 비-인간 동물
ES2715949T3 (es) 2013-10-15 2019-06-07 Regeneron Pharma Animales con IL-15 humanizada
WO2015077071A1 (en) 2013-11-19 2015-05-28 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
EP3430898A1 (en) 2013-11-19 2019-01-23 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
DK3129400T3 (da) 2014-04-08 2020-06-08 Regeneron Pharma Ikke-humane dyr med humaniserede Fc-gamma-receptorer
NO2785538T3 (cg-RX-API-DMAC7.html) 2014-05-07 2018-08-04
PT3482629T (pt) 2014-05-19 2021-02-18 Univ Yale Animais não humanos geneticamente modificados que expressam epo humana
BR112016029650A2 (pt) 2014-06-19 2017-10-24 Regeneron Pharma roedor, polipeptídeo pd-1, célula isolada ou tecido de roedor, célula-tronco embrionária de roedor, métodos de produzir um roedor, de reduzir o crescimento de tumor em um roedor, de matar células tumorais em um roedor e de avaliar as propriedades farmacocinéticas de uma droga que direciona pd-1 humano, e, modelo de tumor de roedor?
PL3689140T3 (pl) 2014-11-24 2022-09-05 Regeneron Pharmaceuticals, Inc. Zwierzęta inne niż ludzie eksprymujące humanizowany kompleks CD3
IL286403B2 (en) 2014-12-05 2023-10-01 Regeneron Pharma Non-human animals possess a humanized CLUSTER OF DIFFERENTIATION 47 gene

Similar Documents

Publication Publication Date Title
JP2018500012A5 (cg-RX-API-DMAC7.html)
JP7649370B2 (ja) 抗ｋｒａｓ－ｇ１２ｄ ｔ細胞受容体
Ma et al. Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth
JP7168641B2 (ja) 刺激性骨髄系細胞及び非刺激性骨髄系細胞の調節
JP6945444B2 (ja) 高親和性ｐｄ−１薬剤とその使用方法
Briukhovetska et al. T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis
AU2017355218B2 (en) Immunologically discernible cell surface variants for use in cell therapy
JP7280827B2 (ja) Ａｘｌまたはｒｏｒ２に対するキメラ抗原受容体およびその使用方法
JP2019047818A5 (cg-RX-API-DMAC7.html)
JP7611836B2 (ja) 抗原特異的ｔ細胞の同定のための組成物と方法
JP2021166522A (ja) キメラ抗原受容体組成物
RU2017123357A (ru) Животные, отличные от человека, имеющие гуманизированный ген кластера дифференцировки 47
CA2959821A1 (en) Compositions and methods for inducing phagocytosis of mhc class i positive cells and countering anti-cd47/sirpa resistance
WO2016023001A1 (en) Multispecific high affinity pd-1 agents and methods of use
US20170267755A1 (en) Isolated anti-mesothelin antibodies, conjugates and uses thereof
JP2016514099A5 (cg-RX-API-DMAC7.html)
JP2017521060A5 (cg-RX-API-DMAC7.html)
CN109152837A (zh) 用于确定和实现抗cd47药剂治疗癌症的治疗有效剂量的方法
JP6630026B1 (ja) 免疫チェックポイント阻害剤によるがん治療の効果を評価するためのバイオマーカー
JP2018070640A (ja) 幹細胞増強治療法
CN114207117A (zh) 用于调节巨噬细胞活性的方法
CN111629715A (zh) 通过调节细胞活化状态改变体内免疫细胞的炎症状态
Chao et al. Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma
JP5756014B2 (ja) がんの診断および治療のためのｖｈｚ
Tachibana et al. Tight junction modulating bioprobes for drug delivery system to the brain: a review